عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
3764371749
(Number (ISBN
9783764371746
NATIONAL BIBLIOGRAPHY NUMBER
Number
b435307
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Advances in targeted cancer therapy /
General Material Designation
[Book]
First Statement of Responsibility
edited by Richard M. Schultz
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Boston :
Name of Publisher, Distributor, etc.
Birkhäuser,
Date of Publication, Distribution, etc.
©2005
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (vii, 303 pages) :
Other Physical Details
illustrations
SERIES
Series Title
Progress in drug research ;
Volume Designation
63
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references
CONTENTS NOTE
Text of Note
Dawn of a new era in molecular cancer therapeutics -- Obstacles and opportunities in the clinical development of targeted therapeutics -- Tumor models for preclinical development of targeted agents -- Angiogenesis inhibitors: what is the clinical future? -- Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy -- Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development -- Targeted histone deacetylase inhibition for cancer prevention and therapy -- Inhibitors of cyclin-dependent kinase modulators for cancer therapy -- Targeting cyclooxygenase-2 for cancer prevention and treatment -- Antisense approaches in drug discovery and development -- Preclinical development of Alimta (Pemetrexed LY231514), a multitargeted antifolate
0
SUMMARY OR ABSTRACT
Text of Note
This volume is the first book to cover the general topic of targeted cancer therapy. It presents a range of targets such as tumor angiogenesis, cell cycle control and cell signalling, COX-2, apoptosis/cell survival, invasion and metastasis and approaches like kinase inhibitors, antisense, and antibody-based therapeutics. The emphasis is on preclinical development, including target validation, development of biomarkers, strategies for combination approaches, and development of resistance. The particular challenges involved in translating these data to clinical application are discussed
SYSTEM REQUIREMENTS NOTE (ELECTRONIC RESOURCES)
Text of Note
Mode of access: World Wide Web
OTHER EDITION IN ANOTHER MEDIUM
Title
Advances in targeted cancer therapy.
Title
Advances in targeted cancer therapy.
International Standard Book Number
9783764371746
PIECE
Title
OhioLINK electronic book center
Title
SpringerLink
TOPICAL NAME USED AS SUBJECT
Cancer-- Chemotherapy
Drug targeting
Antineoplastic Agents-- therapeutic use
Drug Delivery Systems
Neoplasms-- drug therapy
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Schultz, Richard M
CORPORATE BODY NAME - ALTERNATIVE RESPONSIBILITY
Ohio Library and Information Network
ORIGINATING SOURCE
Date of Transaction
20090406013159.0
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
